Related Experiment Video
Updated: Sep 28, 2025

06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
13.8K
An Integrated Phenotypic and Genotypic Approach Reveals a High-Risk Subtype Association for EBF3 Missense Variants
Cole A Deisseroth1,2, Vanesa C Lerma2,3, Christina L Magyar1,2,4,5
1Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
Annals of Neurology
|March 27, 2022
Summary
Early B-cell Factor-3 (EBF3) gene variants disrupting the zinc finger domain are linked to increased symptom severity in neurodevelopmental disorders (NDD). This finding may help predict clinical outcomes for NDD patients with EBF3 variants.
Area of Science:
- Neurogenetics
- Developmental Neuroscience
Background:
- Collier/Olf/EBF (COE) transcription factors play crucial roles in nervous system development.
- Early B-cell Factor-3 (EBF3) is the only COE member with a confirmed link to autism spectrum/neurodevelopmental disorders (NDD) via loss-of-function variants.
Purpose of the Study:
- To investigate the association between EBF3 variant type and location and symptom severity in EBF3-related NDD.
- To establish genotype-phenotype correlations for EBF3 variants.
Main Methods:
- Phenotypic assessment of 41 individuals with EBF3-related NDD, combined with a literature meta-analysis of 83 individuals.
- Development of quantitative diagnostic phenotypic and symptom severity scales.
- In vivo (Drosophila melanogaster) and in vitro assays to assess the functional impact of EBF3 variants on the DNA-binding domain (DBD) and zinc finger (ZNF) domains.
Main Results:
- Patient symptom severity correlates with EBF3 missense variants that disrupt the ZNF domain, essential for DNA binding.
- ZNF-associated variants impaired transcriptional activation and failed to restore viability in a fruit fly model.
- A recurrent variant in the DBD (EBF3 p.Arg209Trp) showed partial rescue of viability and preserved transcriptional activation.
Conclusions:
- A significant association exists between ZNF perturbations in EBF3 and increased symptom severity in NDD patients.
- This genotype-phenotype correlation offers potential predictive clinical value for individuals with newly identified EBF3 variants.

